Literature DB >> 23193144

Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

Dirk J van Veldhuisen, John J V McMurray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23193144     DOI： 10.1093/eurjhf/hfs194

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  3 in total

Review 1.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

2.  Cardiac structural remodeling in hypertensive cardiomyopathy.

Authors:  Si-Jia Sun; Jia-Lu Yao; Lang-Biao Xu; Qing Rui; Nan-Nan Zhang; Min Chen; Yu-Feng Jiang; Hua-Jia Yang; Ya-Feng Zhou
Journal:  Hypertens Res       Date:  2016-12-22       Impact factor: 3.872

Review 3.  Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?

Authors:  Jia Li; Peter Moritz Becher; Stefan Blankenberg; Dirk Westermann
Journal:  Cardiol Res Pract       Date:  2013-10-24       Impact factor: 1.866
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.